RocketDNA Ltd. (ASX:RKT)
Australia · Delayed Price · Currency is AUD 0.0210
0.00 (0.00%)
Sep 4, 2026, 3:55 PM AEST
RocketDNA Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9.35 | 7.68 | 7.24 | 6.14 | 5.73 | 4.58 | |
Revenue Growth | 31.91% | 6.10% | 18.00% | 7.01% | 25.16% | 36.00% |
Cost of Revenue | 5.54 | 4.31 | 3.61 | 3.01 | 2.93 | 2.15 |
Gross Profit | 3.81 | 3.37 | 3.64 | 3.13 | 2.8 | 2.43 |
Selling, General & Admin | 6.1 | 5.52 | 4.79 | 4.45 | 4.86 | 4.11 |
Amortization of Goodwill & Intangibles | 0.22 | 0.13 | 0.04 | 0.01 | 0.01 | 0.03 |
Other Operating Expenses | -0.02 | -0.02 | -0.05 | -0.02 | -0.02 | -0.04 |
Operating Expenses | 6.79 | 6.11 | 5.19 | 4.8 | 5.19 | 4.19 |
Operating Income | -2.98 | -2.73 | -1.55 | -1.67 | -2.39 | -1.77 |
Interest Expense | -0.19 | -0.2 | -0.29 | -0.08 | -0.01 | -0 |
Interest & Investment Income | 0.12 | 0.1 | 0.05 | 0.03 | 0.02 | 0.01 |
EBT Excluding Unusual Items | -3.03 | -2.83 | -1.8 | -1.71 | -2.38 | -1.76 |
Impairment of Goodwill | - | - | - | -0.2 | - | - |
Gain (Loss) on Sale of Assets | 0.07 | 0.04 | 0.01 | 0.12 | 0.04 | 0.01 |
Pretax Income | -2.96 | -2.79 | -1.79 | -1.79 | -2.34 | -1.74 |
Income Tax Expense | -0.02 | -0.03 | 0.14 | 0.07 | 0.09 | -0.04 |
Earnings From Continuing Operations | -2.94 | -2.76 | -1.93 | -1.86 | -2.42 | -1.71 |
Earnings From Discontinued Operations | - | - | - | - | 0.45 | -1.88 |
Net Income to Company | -2.94 | -2.76 | -1.93 | -1.86 | -1.97 | -3.59 |
Minority Interest in Earnings | -0.19 | -0.06 | 0 | 0.09 | 0.05 | -0.03 |
Net Income | -3.13 | -2.82 | -1.92 | -1.77 | -1.92 | -3.62 |
Net Income to Common | -3.13 | -2.82 | -1.92 | -1.77 | -1.92 | -3.62 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,084 | 942 | 682 | 520 | 512 | 505 |
Shares Outstanding (Diluted) | 1,084 | 942 | 682 | 520 | 512 | 505 |
Shares Change | 34.15% | 38.21% | 31.00% | 1.74% | 1.30% | 250.25% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.04 | -3.26 | -1.46 | -1.66 | -2.34 | -3.68 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 |
Gross Margin | 40.73% | 43.91% | 50.22% | 50.92% | 48.87% | 53.01% |
Operating Margin | -31.84% | -35.57% | -21.45% | -27.25% | -41.59% | -38.54% |
Profit Margin | -33.51% | -36.64% | -26.57% | -28.83% | -33.54% | -78.96% |
Free Cash Flow Margin | -21.79% | -42.47% | -20.14% | -27.06% | -40.84% | -80.23% |
EBITDA | -1.51 | -1.53 | -0.83 | -0.92 | -1.65 | -0.8 |
EBITDA Margin | -16.12% | -19.86% | -11.40% | -15.06% | -28.81% | -17.37% |
D&A For EBITDA | 1.47 | 1.21 | 0.73 | 0.75 | 0.73 | 0.97 |
EBIT | -2.98 | -2.73 | -1.55 | -1.67 | -2.39 | -1.77 |
EBIT Margin | -31.84% | -35.57% | -21.45% | -27.25% | -41.59% | -38.54% |